Macquarie Group
TRIL

Macquarie Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Macquarie Group’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-163,326
Closed -$2.4M – 2502
2020
Q4 		$2.4M Buy
+163,326
New +$2.4M ﹤0.01% 1054